Trial Profile
Entecavir Improves Liver Function and Fibrosis in Patients with Hepatitis B Virus-associated Liver Cirrhosis: A 2 Years-Multicenter Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B; Liver cirrhosis
- Focus Pharmacodynamics
- 31 Aug 2015 New trial record